查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566949

血管隔离医用黏剂市场：按程序、最终用户：2024-2033 年全球机会分析与产业预测

Vascular Sealing Medical Glue Market By Procedure (Revascularization, Others) , By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，血管密封剂医用黏剂市场估值为7亿美元，预计2024年至2033年复合年增长率为7.3%，到2033年达到14亿美元。

血管黏剂是一种具有高黏合性和止血性能的外科黏剂，用于组织封闭和加固。这些黏剂在受伤组织之间以及组织与植入生物材料之间建立功能连接方面发挥着至关重要的作用。开发这种黏剂是为了最大限度地减少对传统手术中有用的手术缝合和机械组织融合方法的需求。这是因为与传统方法相比，血管密封黏剂可促进组织再生和癒合，降低感染风险，并最大限度地减少组织创伤。市面上的天然医用黏剂包括纤维蛋白黏剂和胶原蛋白产品，它们具有很高的黏合效果。

全球血管闭塞医用黏剂市场的成长是由心血管疾病盛行率的惊人上升以及血管成形术和冠状动脉绕道手术术等手术需求的相应增加所推动的，这是推动医用黏剂需求的主要因素。根据世界心臟联盟的数据，心血管疾病是全球第一大死因，超过其他原因。每年约有 2050 万人死于心血管疾病。其中，85%是由于冠状动脉疾病（如心臟病）和脑血管疾病（如中风）引起的。此外，老年人口的增加对市场成长做出了重大贡献。这是因为老年人更容易患心臟疾病，并且经常需要手术来解决静脉曲张和动脉硬化等问题，这增加了对医用黏剂来密封血管的需求。根据西班牙心臟学会官方刊物Revista Espanola de Cardiologia发表的论文，心臟疾病是81% 65岁以上成年人的主要死因。此外，由于更快的恢復时间和更短的住院时间，患者和医疗保健提供者对微创手术的偏好日益增加，也推动了市场的成长。然而，与血管闭合用医用黏剂相关的安全问题正在阻碍市场成长。例如，一些黏剂具有细胞毒性且吸收性差，这限制了它们在医疗保健环境中的需求。此外，医用黏剂无法提供充分且即时的密封、感染风险增加以及癒合延迟也是市场的主要阻碍因素。相反，为了降低手术部位感染的风险，製造商正在开发具有抗菌特性的用于血管闭合的医用黏剂，以确保术后护理和患者安全。此外，医用黏剂配方中不断的技术创新以增强黏合强度预计将为预测期内的市场扩张提供利润丰厚的机会。

全球血管密封剂医用黏剂市场按程序、最终用户和地区细分。依程序，市场分为重组和其他。依最终使用者分为医院、专科诊所和门诊手术中心。按地区划分，对北美、欧洲、亚太地区和拉丁美洲地区市场进行了分析。

主要发现

  • 从手术方式来看，重组在 2023 年占据了市场占有率。
  • 按最终用户划分，医院领域在 2023 年呈现最高成长。
  • 按地区划分，北美将在 2023 年引领市场，而亚太地区预计在预测期内复合年增长率最高。

可以自订此报告（需要额外的成本和时间表）。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章血管隔离医用黏剂市场：依程序

  • 市场概况
  • 重组
  • 其他的

第五章血管隔离医用黏剂市场：依最终用户分类

  • 市场概况
  • 医院
  • 专科诊所
  • 门诊手术中心

第六章血管隔离医用黏剂市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国血管闭合用医用黏剂市场
    • 加拿大血管密封医用黏剂市场
    • 墨西哥血管闭合医用黏剂市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国血管封闭医用黏剂市场
    • 法国血管封闭医用黏剂市场
    • 英国血管闭合医用黏剂市场
    • 义大利血管封闭医用黏剂市场
    • 西班牙血管闭合医用黏剂市场
    • 其他欧洲国家血管闭合医用黏剂市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本血管闭合用医用黏剂市场
    • 中国血管闭合医用黏剂市场
    • 澳洲血管封闭医用黏剂市场
    • 印度血管密封医用黏剂市场
    • 韩国血管闭合用医用黏剂市场
    • 其他亚太血管闭塞医用黏剂市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西血管封闭医用黏剂市场
    • 沙乌地阿拉伯血管隔离医用黏剂市场
    • 南非血管闭合医用黏剂市场
    • 其他拉丁美洲/中东/非洲血管闭合用医用黏剂市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • Baxter International Inc.
  • Becton, Dickinson And Company
  • Artivion, Inc.
  • Success Bio-tech
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • Johnson And Johnson
  • Medtronic
简介目录
Product Code: A324057

The vascular sealing medical glue market was valued at $0.7 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

Vascular sealing medical glue is a surgical adhesive that possesses high adhesive and hemostatic properties, and is used to seal and reinforce tissues. These adhesives are play a pivotal role in creating functional connections between damaged tissues and between tissues and implanted biomaterials. They are majorly developed to minimize the use of surgical sutures and mechanical methods of tissue fusion, which are useful in conventional surgeries. This is attributed to the fact that vascular sealing glues promote tissue regeneration and healing, mitigate the risk of infection, and minimize tissue trauma as compared to conventional methods. Natural medical adhesives available in the market include fibrin adhesives and collagen-based products, which are highly effective in adhesion.

The growth of the global vascular sealing medical glue market is majorly driven by alarming rise in prevalence of cardiovascular diseases and corresponding increase in need for surgeries, such as angioplasty and coronary artery bypass grafting, are boosting the demand for vascular sealing medical glue. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases and often require procedures to address issues such as varicose veins and atherosclerosis, thus increasing the need for vascular sealing glues. As per the article published by the Revista Espanola de Cardiologia-the official publication of the Spanish Society of Cardiology-coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers due to quicker recovery times and reduced hospital stays fosters the growth of the market. However, safety concerns associated with vascular sealing medical glue hamper the growth of the market. For instance, some adhesives are cytotoxic and are poorly absorbed, which limit their demand in healthcare settings. Furthermore, inability to medical adhesives to provide adequate and immediate seal, increased risk of infection, and delayed healing act as the key deterrent factors of the market. On the contrary, to reduce the risk of infection at the surgical sites, manufacturers are developing vascular sealing medical glue with antimicrobial properties, thus ensuring post-operative care and patient safety. In addition, continuous innovations in the formulation of medical glues to enhance their adhesive strength are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The global vascular sealing medical glue market is segmented into procedure, end user, and region. By procedure, the market is categorized into revascularization and others. On the basis of end user, it is divided into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • By procedure, the revascularization segment dominated the market share in 2023.
  • On the basis of end user, the hospitals segment exhibited the highest growth in 2023.
  • Region wise, North America lead the market in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global vascular sealing medical glue market include Baxter International Inc., Becton, Dickinson and Company, Artivion, Inc., Success Bio-tech, Integra LifeSciences Holdings Corporation, Stryker Corporation, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Procedure

  • Revascularization
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Artivion, Inc.
    • Success Bio-tech
    • Integra LifeSciences Holdings Corporation
    • Stryker Corporation
    • Abbott Laboratories
    • Terumo Corporation
    • Johnson & Johnson
    • Medtronic

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Procedure
  • 4.2. Revascularization
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Others
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Specialty Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: VASCULAR SEALING MEDICAL GLUE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Procedure
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Vascular Sealing Medical Glue Market
      • 6.2.5.1. Market Size and Forecast, By Procedure
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Vascular Sealing Medical Glue Market
      • 6.2.6.1. Market Size and Forecast, By Procedure
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Vascular Sealing Medical Glue Market
      • 6.2.7.1. Market Size and Forecast, By Procedure
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Procedure
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Vascular Sealing Medical Glue Market
      • 6.3.5.1. Market Size and Forecast, By Procedure
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Vascular Sealing Medical Glue Market
      • 6.3.6.1. Market Size and Forecast, By Procedure
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Vascular Sealing Medical Glue Market
      • 6.3.7.1. Market Size and Forecast, By Procedure
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Vascular Sealing Medical Glue Market
      • 6.3.8.1. Market Size and Forecast, By Procedure
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Vascular Sealing Medical Glue Market
      • 6.3.9.1. Market Size and Forecast, By Procedure
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Vascular Sealing Medical Glue Market
      • 6.3.10.1. Market Size and Forecast, By Procedure
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Procedure
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Vascular Sealing Medical Glue Market
      • 6.4.5.1. Market Size and Forecast, By Procedure
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Vascular Sealing Medical Glue Market
      • 6.4.6.1. Market Size and Forecast, By Procedure
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. Australia Vascular Sealing Medical Glue Market
      • 6.4.7.1. Market Size and Forecast, By Procedure
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. India Vascular Sealing Medical Glue Market
      • 6.4.8.1. Market Size and Forecast, By Procedure
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Vascular Sealing Medical Glue Market
      • 6.4.9.1. Market Size and Forecast, By Procedure
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Vascular Sealing Medical Glue Market
      • 6.4.10.1. Market Size and Forecast, By Procedure
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Procedure
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Vascular Sealing Medical Glue Market
      • 6.5.5.1. Market Size and Forecast, By Procedure
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Vascular Sealing Medical Glue Market
      • 6.5.6.1. Market Size and Forecast, By Procedure
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Vascular Sealing Medical Glue Market
      • 6.5.7.1. Market Size and Forecast, By Procedure
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Vascular Sealing Medical Glue Market
      • 6.5.8.1. Market Size and Forecast, By Procedure
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Baxter International Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Becton, Dickinson And Company
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Artivion, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Success Bio-tech
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Integra LifeSciences Holdings Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Stryker Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Abbott Laboratories
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Terumo Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Johnson And Johnson
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Medtronic
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments